2026 ESMO USA in Focus: Lung and Sarcoma

Learn How to Claim Your Credit

 

Total Health, in partnership with the European Society for Medical Oncology (ESMO)—a global authority representing more than 50,000 oncology professionals— is proud to present a state-of-the-art program designed to deliver exclusive U.S.-based updates from the ESMO Sarcoma and Rare Cancers Congress 2026, as well as the 2025 ESMO Annual Congress.

This free, 1-day symposium for healthcare providers will spotlight the most important advances across the sarcoma and rare cancers, as well as the lung cancer continuum.

Event Page

 

Accreditation Information | 6.00

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
  • Amedco LLC designates this activity for a maximum of 6.00 ANCC contact hours.

  • Amedco LLC designates this live activity for a maximum of 6.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Amedco LLC designates this activity for a maximum of 6.00 knowledge-based CPE contact hours. JA4008163-9999-25-197-L01-P | JA4008163-9999-25-197-L01-T

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior

  • Acknowledgement of Financial Commercial Support
    No financial commercial support was received for this educational activity.

    Acknowledgement of In-Kind Commercial Support
    No in-kind commercial support was received for this educational activity.

    Satisfactory Completion
    Learners must complete an evaluation form to receive a certificate of completion. If you need MOC credit, you also need to pass a posttest with a score of at least 80%. Your chosen sessions must be attended in their entirety. You must attend the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

    Joint Accreditation Statement
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Amedco Joint Accreditation Provider Number: 4008163

    Professions in scope for this activity are listed below.

    Physicians
    Amedco LLC designates this live activity for a maximum of 6.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists & Pharmacy Technicians
    Amedco LLC designates this activity for a maximum of 6.00
    knowledge-based CPE contact hours. JA4008163-9999-26-110-L01-P | UAN JA4008163-9999-26-110-L01-T

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

    Nurses
    Amedco LLC designates this activity for a maximum of 6.00 ANCC contact hours.

    American Board of Internal Medicine (ABIM) MOC
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM)
    Maintenance of Certification Learner Notification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS. Credits are generally reported during the first week of each month for those who claimed during the month prior.

    Objectives - After Attending This Program You Should Be Able To
    1. Summarize recent advances in the diagnosis, staging, and treatment of lung cancers and sarcomas.
    2. Interpret emerging clinical trial data and its implications for current oncology practice.
    3. Enhance collaboration across the multidisciplinary cancer care team to improve patient outcomes.

    Disclosure of Conflict of Interest
    The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

    All individuals in a position to control the content of CE are listed below.

    Name Commercial Interest:Relationship
    Thierry Alcindor NA
    Ryan Denu NA
    Britt Erickson GSK, Merck, Gilead, Natera, Eli Lilly, Abbvie:Consultant
    Michael Heinrich NA
    Robert Kratzke NA
    Scott Okuno NA
    Kaushal Parikh Regeneron:Research Grant Overall Principal Investigator AstraZeneca, ImmunityBio, Rigel Pharmaceuticals, EMD Serono, Takeda, Johnson and Johnson:Scientific/Medical Advisory Board Member
    Ugur Sener Merck&Co, Alexion Pharmaceuticals:Consultant
    Aditi Singh NA
    Everett Vokes AbbVie, AstraZeneca, BioNTech, Boehringer-Ingelheim, Day One, Delcath, EMD Serono, Eikon Therapeutics, Foresight Diagnostics, Genmab, GlaxoSmithKline, Marengo, Merus, MJH Lifesciences, Translational Drug Development LLC:Consultant
    Reyna Wilhelm NA
    Justin Kaiser NA

    How to Get Your Certificate
    1. Go to thc.cmecertificateonline.com
    2. Click on the 2026 ESMO USA in Focus: Lung and Sarcoma link.
    3. Evaluate the meeting.
    4. Print, download, or save your certificate for your records.
    5. If you lose your certificate, or need help, go to help.cmecertificateonline.com

 

How to Get Your Certificate

  1. Go to thc.cmecertificateonline.com

    Evaluate the meeting.

  2. Print, download, or save your certificate for your records.

  3. If you lose your certificate, or need help, go to help.cmecertificateonline.com

 
Previous
Previous

2026 ESMO USA in Focus: Breast Cancer - EAST

Next
Next

2026 Cancer Updates GI & Breast, Houston